Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073190 · ClinicalTrials.gov registry record · Phase 1
Patient- and Physician-Based Osteoporosis Education
A Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 30,000
- Enrollment target
- 1
- Study location
NCT00073190 is a Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 30,000 participants, above the 1,189-participant average among 84 other Osteoporosis trials with a reported enrollment target (2423% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00073190, a Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment of osteoporosis.
Conditions Studied
Interventions
- BEHAVIORAL Osteoporosis Education
Study Locations (1)
Massachusetts
- Daniel H. Solomon MD, MPH - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00073190
The ClinicalTrials.gov registry entry for NCT00073190 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,189-participant average among 84 other Osteoporosis trials with a reported enrollment target (2423% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Osteoporosis Education is the first listed.
NCT00073190 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00073190 about?
NCT00073190 is a clinical study titled "Patient- and Physician-Based Osteoporosis Education". Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment o...
What is the current status of trial NCT00073190?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30,000 participants. The study started on 2003-09. Estimated completion is 2006-06.
What conditions does trial NCT00073190 study?
This clinical trial studies the following conditions: Osteoporosis, Osteoporosis, Postmenopausal.
What interventions are being tested in trial NCT00073190?
The interventions under investigation include: Osteoporosis Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00073190?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00073190 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
ACTIVE NOT RECRUITING · Phase 1
-
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
COMPLETED · Phase 1
-
Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects
COMPLETED · Phase 1
-
Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study
COMPLETED · Phase 1
-
A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women
COMPLETED · Phase 1
-
A Comparison Study of PF708 and Forteo in Healthy Subjects
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.